Skip to main content
Clinical Trials/NCT05776316
NCT05776316RecruitingNot Applicable

Culturally Response Integrated Harm Reduction Services for Black and Latinx People Who Use Drugs

NYU Langone Health5 sites in 1 country200 target enrollmentStarted: November 25, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
200
Locations
5
Primary Endpoint
Percentage of Participants who Attend At least 1 Harm Reduction (HR) Session after Introductory HR Session

Study Overview

Brief Summary

The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • at least 18 years of age
  • self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria
  • English or Spanish speaking
  • able to provide informed consent.

Exclusion Criteria

  • inability to provide informed consent or participate in the study procedures as proposed in the consent
  • active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder)
  • an unwillingness to be randomized.
  • are prisoners

Arms & Interventions

IHRI

Experimental

Integrated harm reduction intervention (IHRI) program tailored specifically for highly marginalized Black and Latinx people who use drugs (PWUDs). The IHRI lasts 8 weeks in duration, with the first 4 weeks consisting of weekly education lessons provided by the IHRI care coordinator. The subsequent 4 weeks will involve individualized identification of vulnerabilities in the social determinants of health (SDOH) for the purposes of making informed referrals to relevant partnering social service organizations. Participants will also be exposed to service encounters through mobile vans in which staff offer information to PWUD on syringe exchange, clean user kits, naloxone use, and fentanyl strip distribution.

Intervention: Integrated Harm Reduction Intervention (IHRI) (Behavioral)

HR SAU

No Intervention

Harm reduction services as usual (HR SAU). Participants will be exposed to service encounters through the mobile vans in which staff offer information to PWUD on syringe exchange, clean user kits, naloxone use, and fentanyl strip distribution.

Outcomes

Primary Outcomes

Percentage of Participants who Attend At least 1 Harm Reduction (HR) Session after Introductory HR Session

Time Frame: Up to Week 8

Measure of engagement.

Percentage of Participants who Attend at least 3 HR Sessions in Total

Time Frame: Up to Week 8

Measure of engagement.

Secondary Outcomes

  • Change from Baseline in Brief Quality of Life Scale Score(Baseline, Week 8)
  • Change from Baseline in Number of Days of Opioid/Other Stimulant Use(Baseline, Week 8)
  • Change from Baseline in Overdose Risk Assessment Tool Score(Baseline, Week 8)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials